ProQR Therapeutics BV Cash Flow Reinvestment Rate
ProQR Therapeutics BV cash flow reinvestment rate. ProQR Therapeutics BV (PRQR) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $225.00K (capex $136.00K plus investments $-89.00K) from operating cash flow of $44.73 Million. Explore ProQR Therapeutics BV (PRQR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ProQR Therapeutics BV (2023–2023)
Cash flow reinvestment rate of ProQR Therapeutics BV from 2023 to 2023. Historical reinvestment intensity for ProQR Therapeutics BV across 1 annual periods. Explore ProQR Therapeutics BV capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
ProQR Therapeutics BV Cash Flow Reinvestment Rate by Year (2023–2023)
ProQR Therapeutics BV cash flow reinvestment rate by year from 2023 to 2023. Year-by-year capital reinvestment analysis for ProQR Therapeutics BV. For the full cash flow conversion analysis, see cash efficiency ratio of ProQR Therapeutics BV.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.26x | $5.65 Million | $21.55 Million | $1.37 Million | — |